Compare J.B.Chemicals with Fresenius Kabi Onco. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs FRESENIUS KABI ONCO. - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS FRESENIUS KABI ONCO. J.B.CHEMICALS/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 21.7 22.1 98.0% View Chart
P/BV x 3.9 3.1 125.4% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 J.B.CHEMICALS   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
FRESENIUS KABI ONCO.
Mar-13
J.B.CHEMICALS/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs363176 206.3%   
Low Rs25579 324.8%   
Sales per share (Unadj.) Rs169.137.7 448.8%  
Earnings per share (Unadj.) Rs16.65.1 325.9%  
Cash flow per share (Unadj.) Rs23.46.7 348.3%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs172.542.5 405.5%  
Shares outstanding (eoy) m83.57158.23 52.8%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.83.4 54.1%   
Avg P/E ratio x18.625.0 74.5%  
P/CF ratio (eoy) x13.218.9 69.7%  
Price / Book Value ratio x1.83.0 59.9%  
Dividend payout %12.00-   
Avg Mkt Cap Rs m25,82720,135 128.3%   
No. of employees `0003.81.2 327.4%   
Total wages/salary Rs m2,511703 357.1%   
Avg. sales/employee Rs Th3,747.45,176.2 72.4%   
Avg. wages/employee Rs Th665.7610.4 109.1%   
Avg. net profit/employee Rs Th367.8699.6 52.6%   
INCOME DATA
Net Sales Rs m14,1355,963 237.0%  
Other income Rs m36618 2,032.2%   
Total revenues Rs m14,5015,981 242.4%   
Gross profit Rs m2,1781,430 152.3%  
Depreciation Rs m570258 220.9%   
Interest Rs m35-26 -134.2%   
Profit before tax Rs m1,9401,216 159.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m552342 161.4%   
Profit after tax Rs m1,387806 172.1%  
Gross profit margin %15.424.0 64.3%  
Effective tax rate %28.528.1 101.2%   
Net profit margin %9.813.5 72.6%  
BALANCE SHEET DATA
Current assets Rs m10,4705,102 205.2%   
Current liabilities Rs m2,7492,385 115.2%   
Net working cap to sales %54.645.6 119.9%  
Current ratio x3.82.1 178.1%  
Inventory Days Days55150 36.8%  
Debtors Days Days78113 68.5%  
Net fixed assets Rs m5,8115,148 112.9%   
Share capital Rs m167158 105.6%   
"Free" reserves Rs m14,2486,556 217.3%   
Net worth Rs m14,4166,732 214.1%   
Long term debt Rs m0952 0.0%   
Total assets Rs m17,64910,388 169.9%  
Interest coverage x56.6-45.8 -123.6%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.6 139.5%   
Return on assets %8.17.5 107.3%  
Return on equity %9.612.0 80.4%  
Return on capital %13.714.6 93.8%  
Exports to sales %074.5 0.0%   
Imports to sales %024.8 0.0%   
Exports (fob) Rs mNA4,441 0.0%   
Imports (cif) Rs mNA1,477 0.0%   
Fx inflow Rs m6,1645,298 116.4%   
Fx outflow Rs m1,3341,772 75.3%   
Net fx Rs m4,8293,525 137.0%   
CASH FLOW
From Operations Rs m1,2311,274 96.6%  
From Investments Rs m-208-1,204 17.3%  
From Financial Activity Rs m-595-196 303.5%  
Net Cashflow Rs m427-126 -338.2%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 81.0 0.4%  
Indian inst/Mut Fund % 3.4 0.3 1,130.0%  
FIIs % 3.9 9.6 40.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 9.1 406.6%  
Shareholders   30,437 42,599 71.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   DISHMAN PHARMA  ELDER PHARMA  SUVEN LIFESCIENCES  ALEMBIC PHARMA  WOCKHARDT  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Crude Oil Sees Buying, FPI Equity Inflows Rise, and Top Cues in Focus Today(Pre-Open)

Indian share markets ended marginally lower yesterday as benchmark indices gave up early gains and slipped into the red during the last hour of trading.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

More Views on News

Most Popular

Protect Your Wealth from Fund Managers(Fast Profits Daily)

May 14, 2020

Do you know how much you are paying in fees to your mutual fund? In this video I'll share with you my views.

How Commodity Prices Tell You When Stocks Will Go Up(Fast Profits Daily)

May 20, 2020

Commodity prices often provide clues to big moves in stock markets. In today's video, I'll explain this link.

This 'Essential Product' Smallcap is a Must Have for a 'Covid-19' Immune Portfolio(Profit Hunter)

May 19, 2020

This smallcap company needs no stimulus measures to do well in the long term.

Which Stocks Should You Buy, Sell, and Hold in the Market Today?(Profit Hunter)

May 21, 2020

The coronavirus led uncertainty refuses to go away from the markets. Here's what retail investors should do with their stocks...

Why Buffet - and you - should study Quantum Liquid Fund(The Honest Truth)

May 14, 2020

Ajit Dayal on how Quantum Liquid Fund and Warren Buffett have similar investing styles.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


May 26, 2020 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS